Martyn P, Allan B
Department of Obstetrics and Gynecology, Foothills Hospital, Calgary, Canada.
J Am Assoc Gynecol Laparosc. 1998 May;5(2):115-8. doi: 10.1016/s1074-3804(98)80075-3.
To assess long-term outcome of endometrial ablation for treatment of menorrhagia.
Five-year, prospective longitudinal study (Canadian Task Force classification II=1).
University teaching hospital.
The first 301 women in a continuing series of over 550 patients undergoing hysteroscopic endometrial ablation.
Hysteroscopic endometrial ablation.
Patients were followed at regular intervals for 24 to 60 months (mean 28 mo). Outcomes were reported in terms of control of menstrual blood loss and menstrual pain with respect to normal uterus, fibroid uterus, dysmenorrhea, and patient age.
Hysteroscopic endometrial ablation is effective for relief of menorrhagia and associated dysmenorrhea in selected patients. Success may decline with increasing length of follow-up.
评估子宫内膜切除术治疗月经过多的长期疗效。
为期五年的前瞻性纵向研究（加拿大工作组分类II = 1）。
大学教学医院。
在超过550例接受宫腔镜子宫内膜切除术的连续病例中，首批301名女性。
宫腔镜子宫内膜切除术。
对患者进行定期随访24至60个月（平均28个月）。报告了关于正常子宫、子宫肌瘤、痛经和患者年龄方面的月经失血控制和痛经情况的结果。
宫腔镜子宫内膜切除术对特定患者缓解月经过多及相关痛经有效。随着随访时间延长，成功率可能会下降。
